Cognitive & Neurotrophic · Research deep dive
PT-141: the cited literature
Every study referenced in the PT-141 monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, PT-141 is studied at 500 mcg – 2 mg per administration, typically as needed, max once in 24 h. The reference walkthrough below maps each citation to what it actually showed.
References covered
Bremelanotide for hypoactive sexual desire disorder
Obstet. Gynecol., 2019
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for PT-141.